Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.
Pes L, Koester SD, Magnusson JP, Chercheja S, Medda F, Abu Ajaj K, Rognan D, Daum S, Nollmann FI, Garcia Fernandez J, Perez Galan P, Walter HK, Warnecke A, Kratz F.
Pes L, et al. Among authors: rognan d.
J Control Release. 2019 Feb 28;296:81-92. doi: 10.1016/j.jconrel.2019.01.010. Epub 2019 Jan 11.
J Control Release. 2019.
PMID: 30639692